These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1204 related articles for article (PubMed ID: 17139428)
1. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538 [TBL] [Abstract][Full Text] [Related]
5. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700 [TBL] [Abstract][Full Text] [Related]
6. Management of combined hepatocellular and cholangiocarcinoma. Kassahun WT; Hauss J Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443 [TBL] [Abstract][Full Text] [Related]
7. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158 [TBL] [Abstract][Full Text] [Related]
8. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy]. Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504 [TBL] [Abstract][Full Text] [Related]
10. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881 [TBL] [Abstract][Full Text] [Related]
12. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787 [No Abstract] [Full Text] [Related]
13. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [TBL] [Abstract][Full Text] [Related]
14. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Stuart KE; Anand AJ; Jenkins RL Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087 [TBL] [Abstract][Full Text] [Related]
16. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Jeon TY; Kim SH; Lee WJ; Lim HK Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315 [TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy]. Tischoff I; Tannapfel A Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941 [TBL] [Abstract][Full Text] [Related]
20. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Sapisochin G; Fidelman N; Roberts JP; Yao FY Liver Transpl; 2011 Aug; 17(8):934-42. PubMed ID: 21438129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]